Entering text into the input field will update the search result below

OSUR Has Soared Recently, Time to Cut Your Position in Half

Apr. 23, 2011 3:48 AM ETOSUR
James Hartje profile picture
James Hartje's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Long/Short Equity, Growth, Value

Seeking Alpha Analyst Since 2009

Back on March 17th, I wrote an article “PRGX & OSUR: Two Cheap Stocks Loaded With Potential” Within the article, I recommended you all to invest in OraSure Technologies (NASDAQ: OSUR) and now looking back I hope you all did.  In that short time (a little over a month) OSUR has continue to beat the market soaring $2.39 a share, a total yield of 37%+, rising from $6.49 to $8.88 per share.

Originally I had predicted that OSUR would be a great investment as I expected it to yield over 37% and pass the $8 range within 12-months, not less than one.  Like Peter Lynch said, “It’s all about finding the next ten-bagger.”  Well if OSUR continues this run, it would yield 440%+ over the course of a year, well over what a ten-bagger is suppose to net.  For those of you who have no idea what OSUR does, below is a brief explanation about the company and what made them a great investment over the past month.

OraSure Technologies (OSURdevelops, manufactures and markets oral fluid diagnostic products and specimen collection devices. I always believe OSUR would be a great investment but never would I believe that the stock would appreciate this quickly.  Most of the rise was due to the fact that OSUR has great value to investors because their new product pipeline that they recently launched as its starting to show lots of value and adding strong results helping boost OSUR’s revenue steam. Adding to this investors are still confident that OSUR will continue to gain momentum when some of their new products get FDA approval.  If this happens, profitability will skyrocket making the stock even more attractive to investors. Currently, I would recommend selling half your position of OSUR due to the significant rise recently and allow yourself to play with some of the house’s money.

The stock still has the potential to go past $10 if all the FDA approvals eventually go through.  The problem is it’s unexpected when the FDA approvals will actually go through so if not the stock could stay at a standstill for a couple months if not longer.  Anyways hope you guys capitalized on the opportunity when I first recommended OSUR, if not make sure to follow through on the next one as I’m hoping there will be manymore ten-baggers to come.

Don’t be a stranger leave a comment below and let me know what you think or send them to my Twitter. Also remember to sign up for Stocks on Wall Street’s Monthly Newsletter.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.